Trial Information
Current as of January 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Experienced (minimum use duration 6 months)
- • Adult (minimum age: 18 years) hearing aid users,
- • Written and spoken German,
- • Ability to understand instruction,
- • Ability to perform tests successfully
- • Ability to describe listening experiences,
- • Ability to attend to the appointments,
- • Healthy outer ear,
- • Moderat to severe Hearing
- • Informed consent as documented by signature.
- Exclusion Criteria:
- • Clinical contraindications deformity of the ear (closed ear canal or absence of pinna),
- • Known hypersensitivity or allergy,
- • Not willing to wear the hearing aid,
- • Fluctuating hearing that could influence the results.
Trial Officials
Matthias Latzel
Study Director
Sonova AG
About Sonova Ag
Sonova AG is a leading global provider of innovative solutions in the field of hearing care and audiology. Headquartered in Switzerland, the company specializes in the development, manufacturing, and distribution of advanced hearing instruments, cochlear implants, and wireless communication systems. With a strong commitment to research and development, Sonova AG focuses on enhancing the quality of life for individuals with hearing loss through cutting-edge technology and personalized care. The organization actively engages in clinical trials to further advance its product offerings and ensure the efficacy and safety of its solutions, reinforcing its position as a trusted leader in the hearing healthcare industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oldenburg, Niedersachsen, Germany
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials